# Microbiome and Volatile Organic Compounds in Patients With CDH

> **NCT03787160** · NA · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 18 (actual)

## Conditions studied

- Congenital Diaphragmatic Hernia

## Interventions

- **DIAGNOSTIC_TEST:** initial VOC
- **DIAGNOSTIC_TEST:** initial fecal microbiome
- **DIAGNOSTIC_TEST:** initial pulmonary microbiome
- **DIAGNOSTIC_TEST:** Maximum oxygen uptake
- **DIAGNOSTIC_TEST:** Functional residual capacity
- **DIETARY_SUPPLEMENT:** Probiotic treatment
- **DIAGNOSTIC_TEST:** VOC probiotic
- **DIAGNOSTIC_TEST:** Fecal microbiome probiotic
- **DIAGNOSTIC_TEST:** Pulmonary microbiome probiotic

## Key facts

- **NCT ID:** NCT03787160
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-22
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03787160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03787160, "Microbiome and Volatile Organic Compounds in Patients With CDH". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03787160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*